Investors Trust’s Novartis NVS Stock Holding History

Investors Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$955K	Hold	10,272	–	–	2.99%	11
2015 Q1	$908K	Hold	10,272	–	–	2.79%	13
2014 Q4	$853K	Sell	10,272 -1,082	-10%	-$89.7K	2.58%	15
2014 Q3	$958K	Sell	11,354 -10,531	-48%	-$852K	1.77%	23
2014 Q2	$1.77M	Sell	21,885 -3,497	-14%	-$275K	1.39%	28
2014 Q1	$1.93M	Sell	25,382 -224	-0.9%	-$16.3K	1.62%	24
2013 Q4	$1.86M	Sell	25,606 -47,379	-65%	-$3.29M	1.45%	25
2013 Q3	$5.02M	Sell	72,985 -19,568	-21%	-$1.29M	0.87%	39
2013 Q2	$5.86M	Buy	+92,553	New	+$6.02M	0.99%	38

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Investors Trust's NVS Position: Q2 2015 in Review

Investors Trust held its Novartis (NVS) position steady in Q2 2015 at 10,272 shares worth $955K. The position accounts for 2.99% of the portfolio, ranked #11.

Investors Trust first reported a position in NVS in Q2 2013 and has held it in 9 quarters since. The position peaked at $5.86M in Q2 2013. 943 funds tracked by Wall St. Rank hold NVS as of Q2 2015.

Investors Trust held 10,272 shares of Novartis worth $955K as of Q2 2015.
Investors Trust left its Novartis share count unchanged in Q2 2015.
Novartis made up 2.99% of Investors Trust's portfolio in Q2 2015, its #11 holding.
Investors Trust first reported a position in Novartis in Q2 2013 and has held it in 9 quarters since.
Investors Trust's Novartis position peaked at $5.86M in Q2 2013.
943 funds tracked by Wall St. Rank held Novartis as of Q2 2015.

Based on Investors Trust's 13F filing for Q2 2015, filed 14 Aug 2015.